Cat: HF-2001
TPO, Human, HEK293 Cells,Tag Free: Product Information
P40225
Human embryonic kidney cell, HEK293-derived human Thrombopoietin/Tpo protein
Ser22-Gly353
52.9 kDa
Solution protein.
Dissolved in sterile PBS buffer. This solution can be diluted into other aqueous buffers. Centrifuge the vial prior to opening.
Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 12 months from date of receipt, -20 to -70 °C as supplied.
Shipping with dry ice.
> 95%, determined by SDS-PAGE.
<0.010 EU per 1 ug of the protein by the LAL method.
Measured in a cell proliferation assay using MO7e human megakaryocytic leukemic cells. The EC50 for this effect is 0.3-2 ng/mL.
TPO, Human, HEK293 Cells,Tag Free:SDS-PAGE & Bioactivity
TPO, Human, HEK293 Cells,Tag Free:Synonyms
Megakaryocyte colony-stimulating factor ; MGDFC-mpl ligand; MKCSF; THPO; Thrombopoietin; Tpo
TPO, Human, HEK293 Cells,Tag Free:Background
Thrombopoietin (Tpo),is a key regulator of megakaryocytopoiesis and thrombopoiesis. It is principally produced in the liver and is bound and internalized by the
receptor Tpo R/c-mpl. Defects in the Tpo-Tpo R signaling pathway are associated with a variety of platelet disorders (1-3). The 353 amino acid (aa) human Tpo precursor
is cleaved to yield the 332 aa mature protein. Mature human Tpo shares approximately 70% aa sequence homology with mouse and rat Tpo. It is an 80-85 kDa protein
that consists of an N-terminal domain with homology to Erythropoietin (Epo) and a C-terminal domain that contains multiple N-linked and O-linked glycosylation sites
(4, 5). Tissue specific alternate splicing of human Tpo generates multiple isoforms with internal deletions, insertions, and/or C-terminal substitutions (6). Tpo promotes the differentiation, proliferation, and maturation of MK and their progenitors (4, 5, 7). Several other cytokines can promote these functions as well but only in cooperation with Tpo (8, 9). Notably, IL-3 independently induces MK development, although its effects are restricted to early in the MK lineage (8, 9). Tpo additionally promotes platelet
production, aggregation, ECM adhesion, and activation (10, 13). It is cleaved by platelet-derived thrombin following Arg191 within the C-terminal domain and subsequently at other sites upon extended digestion (14). Full length Tpo and shorter forms circulate in the plasma (4, 5). The C-terminal domain is not required for binding to Tpo R or inducing MK growth and differentiation (5).
1. Deutsch, V.R. and A. Tomer (2006) Br. J. Haematol. 134:453.
2. Kaushansky, K. (2005) J. Clin. Invest. 115:3339.
3. Li, J. et al. (1999) Br. J. Haematol. 106:345.
4. Bartley, T.D. et al. (1994) Cell 77:1117.
5. de Sauvage, F.J. et al. (1994) Nature 369:533.
6. Marcucci, R. and M. Romano (2008) Biochim. Biophys. Acta 1782:427.
7. Kaushansky, K. et al. (1994) Nature 369:568.
8. Kaushansky, K. et al. (1995) Proc. Natl. Acad. Sci. 92:3234.
9. Broudy, V.C. et al. (1995), Blood 85:1719.
10. Lok, S.I. et al. (1994) Nature 369:565.
11. Chen, J. et al. (1995) Blood 86:4054.
12. Oda, A. et al. (1996) Blood 87:4664.
13. Van Os, E. et al. (2003) Br. J. Haematol. 121:482.
14. Kato, T. et al. (1997) Proc. Natl. Acad. Sci. 94:4669.